Total Payments
$2,960
2024 Payments
$24.42
Companies
24
Transactions
178
Medicare Patients
2,719
Medicare Billing
$312,386
Payment Breakdown by Category
Food & Beverage$2,761 (93.3%)
Education$198.95 (6.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,761 | 175 | 93.3% |
| Education | $198.95 | 2 | 6.7% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$2,960
177 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $840.27 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $357.83 | 17 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $271.53 | 18 | $0 (2021) |
| Braintree Laboratories, Inc. | $205.33 | 12 | $0 (2021) |
| Shire North American Group Inc | $131.28 | 8 | $0 (2019) |
| Allergan Inc. | $127.87 | 8 | $0 (2019) |
| QOL Medical, LLC | $125.66 | 9 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $124.36 | 8 | $0 (2022) |
| PFIZER INC. | $119.66 | 8 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $108.05 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.42 | 1 | ABBVIE INC. ($24.42) |
| 2023 | $64.50 | 3 | AbbVie Inc. ($64.50) |
| 2022 | $559.99 | 29 | ABBVIE INC. ($190.04) |
| 2021 | $833.54 | 49 | AbbVie Inc. ($276.43) |
| 2020 | $278.78 | 16 | AbbVie Inc. ($140.23) |
| 2019 | $425.06 | 27 | AbbVie, Inc. ($90.20) |
| 2018 | $501.12 | 34 | Braintree Laboratories, Inc. ($96.54) |
| 2017 | $272.74 | 19 | Takeda Pharmaceuticals America, Inc. ($98.44) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/13/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/11/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Gastroenterology | ||||||
| 09/14/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Immunology | ||||||
| 09/13/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/31/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $9.30 | General |
| 08/24/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Immunology | ||||||
| 08/16/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Immunology | ||||||
| 08/03/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/02/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Immunology | ||||||
| 07/27/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: VIROLOGY | ||||||
| 07/13/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Immunology | ||||||
| 07/05/2022 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/10/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: Immunology | ||||||
| 06/10/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: Immunology | ||||||
| 05/24/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: Immunology | ||||||
| 05/23/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/18/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/03/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 13 | 432 | 441 | $472,120 | $55,493 |
| 2021 | 18 | 1,126 | 1,269 | $850,983 | $126,607 |
| 2020 | 21 | 1,161 | 1,386 | $836,132 | $130,285 |
Total Patients
2,719
Total Services
3,096
Medicare Billing
$312,386
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 69 | 70 | $113,238 | $13,696 | 12.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 53 | 53 | $64,286 | $9,203 | 14.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 37 | 37 | $44,203 | $6,569 | 14.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 68 | 69 | $87,537 | $5,546 | 6.3% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 22 | 25 | $15,492 | $4,896 | 31.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $58,575 | $4,755 | 8.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 35 | $35,875 | $2,773 | 7.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 15 | $18,420 | $1,948 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $4,086 | $1,715 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,666 | $1,502 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $3,000 | $1,325 | 44.2% |
| 43450 | Dilation of esophagus | Facility | 2022 | 38 | 39 | $22,650 | $1,183 | 5.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,092 | $383.28 | 35.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 166 | 167 | $233,800 | $32,893 | 14.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 110 | 110 | $110,000 | $19,511 | 17.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 84 | 84 | $84,000 | $15,018 | 17.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2021 | 26 | 48 | $24,960 | $9,384 | 37.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 105 | 105 | $105,000 | $8,847 | 8.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 233 | 349 | $55,840 | $7,877 | 14.1% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 87 | 89 | $71,200 | $7,750 | 10.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 52 | 52 | $62,400 | $7,575 | 12.1% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 30 | 30 | $30,000 | $3,913 | 13.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 24 | $5,160 | $3,135 | 60.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 32 | $5,920 | $3,127 | 52.8% |
| 43450 | Dilation of esophagus unguided | Facility | 2021 | 94 | 95 | $28,500 | $2,839 | 10.0% |
About Dr. Roger Siddoway, M.D
Dr. Roger Siddoway, M.D is a Gastroenterology healthcare provider based in St George, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548240310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Siddoway, M.D has received a total of $2,960 in payments from pharmaceutical and medical device companies, with $24.42 received in 2024. These payments were reported across 178 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,761).
As a Medicare-enrolled provider, Siddoway has provided services to 2,719 Medicare beneficiaries, totaling 3,096 services with total Medicare billing of $312,386. Data is available for 3 years (2020–2022), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location St George, UT
- Active Since 01/18/2006
- Last Updated 06/09/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1548240310
Products in Payments
- HUMIRA (Biological) $342.82
- STELARA (Biological) $334.51
- LINZESS (Drug) $198.68
- GATTEX (Drug) $191.76
- Entyvio (Biological) $159.42
- SUPREP (Drug) $138.15
- ZENPEP (Drug) $122.49
- Humira (Biological) $117.35
- CREON (Drug) $109.96
- XELJANZ (Drug) $102.03
- XIFAXAN (Drug) $94.49
- DIFICID (Drug) $90.70
- Sucraid (Drug) $87.91
- MAVYRET (Drug) $73.86
- DUPIXENT (Biological) $65.76
- VIBERZI (Drug) $60.47
- MOTEGRITY (Drug) $56.20
- SKYRIZI (Biological) $53.77
- ENTYVIO (Biological) $51.84
- MOTOFEN (Drug) $41.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in St George
Mr. Brien Miller, D.o, D.O
Gastroenterology — Payments: $4,405
Gastroenterology $4,405
James Bown, M.d, M.D
Gastroenterology — Payments: $4,284
Gastroenterology $4,284
Christoph Woerlein, Md, MD
Gastroenterology — Payments: $2,621
Gastroenterology $2,621
Dr. Edward Frech, Md, MD
Gastroenterology — Payments: $594.67
Gastroenterology $594.67
Dr. Christopher Flannery, Md, MD
Gastroenterology — Payments: $553.25
Gastroenterology $553.25
Dr. Allan Gunnerson, D.o, D.O
Gastroenterology — Payments: $179.26
Gastroenterology $179.26